Dong-A Socio Holdings Co.,Ltd
Financials
Valuation Metrics
Dong-A Socio Holdings Co.,Ltd's Market Cap is ₩5891B. At end of 2025 it was ₩7166B. Ranked #396 of 2,410 in KR market (top 16%), #262 of 779 on KOSPI (top 34%), #43 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 19%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 589.10B KRW | KR#396/2,410 Sec#43/231 |
| Revenue | 1.52T KRW | KR#315/2,410 Sec#11/231 |
| Net Income | 84.87B KRW | KR#279/2,410 Sec#17/231 |
| Total Assets | 2.21T KRW | KR#288/2,410 Sec#11/231 |
| Net Assets | 1.21T KRW | KR#253/2,410 Sec#12/231 |
| Employees | 82 | KR#1,789/2,410 Sec#148/231 |
| Value | ||
| P/E | 6.92x | KR#630/2,410 Sec#28/231 |
| P/B | 0.49x | KR#850/2,410 Sec#37/231 |
| P/S | 0.39x | KR#804/2,410 Sec#29/231 |
| EV/EBITDA | 9.08x | KR#606/2,410 Sec#28/231 |
| FCF Yield | 30.24% | KR#212/2,410 Sec#4/231 |
| Profitability | ||
| ROE | 7.03% | KR#878/2,410 Sec#61/231 |
| ROA | 3.84% | KR#907/2,410 Sec#74/231 |
| Op. Margin | 7.07% | KR#718/2,410 Sec#57/231 |
| Revenue Growth | 10.06% | KR#890/2,410 Sec#87/231 |
| Earnings Growth | -4.53% | KR#854/2,410 Sec#53/231 |
| Financial Health | ||
| Debt Ratio | 82.93% | KR#1,383/2,410 Sec#160/231 |
| Total Debt | 569.88B KRW | KR#285/2,410 Sec#9/231 |
| FCF | 178.13B KRW | KR#125/2,410 Sec#3/231 |
| Cash | 183.91B KRW | KR#292/2,410 Sec#12/231 |
| Current Ratio | 0.82x | KR#1,919/2,410 Sec#187/231 |
| Net Debt/EBITDA | 3.60x | KR#942/2,410 Sec#71/231 |
| Dividend | ||
| Div. Yield | 1.90% | KR#958/2,410 Sec#50/231 |
| Div. Growth | 0.00% | KR—/2,410 Sec—/231 |
| Performance | ||
| 1Y Return | -17.15% | KR#1,041/2,410 Sec#68/231 |
| 1M Return | -7.72% | KR#726/2,410 Sec#76/231 |
| From 52W High | -28.38% | KR#358/2,410 Sec#24/231 |
| 1Y MDD | -36.44% | KR#435/2,410 Sec#30/231 |
| Trading | ||
| Volume | 3,870 shares | KR#2,134/2,410 Sec#213/231 |
| Trading Value | 337.0M KRW | KR#952/2,410 Sec#106/231 |
| Foreign Own. | 17.08% | KR#273/2,410 Sec#15/231 |
| Per Share | ||
| EPS | 12,607 KRW | KR#88/2,410 Sec#7/231 |
| BPS | 179,308 KRW | KR#81/2,410 Sec#4/231 |
Company Info
Dong-A Socio Holdings, established in 1949 and listed on the KOSPI in 1970, transitioned to a holding company structure in 2014. It operates seven reporting divisions including manufacturing and sales of OTC drugs and quasi-drugs, biosimilar and CMO production, logistics, and manufacturing of packaging containers and bottled water, with subsidiaries Dong-A ST and ST Pharm. This holding company structure supports independent decision-making and autonomous management for its subsidiaries, strengthening business competitiveness and securing growth potential. Dong-A Socio Holdings is headquartered in Dongdaemun-gu, Seoul.